Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites.
about
Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyondSSP3 is a novel Plasmodium yoelii sporozoite surface protein with a role in gliding motility.Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigensThrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytesPhase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.In vivo testing of subunit vaccines against malaria sporozoites using a rodent system.Theoretically determined three-dimensional structure for the repeating tetrapeptide unit of the circumsporozoite coat protein of the malaria parasite Plasmodium falciparum.Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes.Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activityApproaching the target: the path towards an effective malaria vaccine.Developmentally regulated infectivity of malaria sporozoites for mosquito salivary glands and the vertebrate hostMonoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesiCombination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei.Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivaxNeutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptideSporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complexMalaria vaccine development.Active and passive immunization against Plasmodium yoelii sporozoitesPreliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites.The antibody response to sporozoites of simian and human malaria parasites: its stage and species specificity and strain cross-reactivity.A nitrocellulose membrane-based ELISA for the detection of Plasmodium infections in mosquitos.Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.Early hepatic stages of Plasmodium berghei: release of circumsporozoite protein and host cellular inflammatory response.Circumsporozoite protein of the human malaria parasite Plasmodium ovale identified with monoclonal antibodies.Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrierPlasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies.Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivativeEnhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimodIsolation of three distinct parasite populations expressing different circumsporozoite proteins from the Philippine strain of Plasmodium knowlesi.Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunityProtective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.A blood stage antigen of Plasmodium falciparum shares determinants with the sporozoite coat proteinImmunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75.Monoclonal antibodies produced against sporozoites of the human parasite Plasmodium malariae abolish infectivity of sporozoites of the simian parasite Plasmodium brasilianumMonoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites.Blood stage-induced Plasmodium brasilianum infection in the squirrel monkey induces antibodies which react with the circumsporozoite protein.Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.
P2860
Q20905953-C84E3E73-5B3B-4C7F-BE5A-D15E3821558BQ27973415-E9AA0BA6-54ED-4634-92F8-91330D2A24F3Q28304173-7FDF97B7-194A-4BA3-A498-A71A46B3CBBCQ30044848-2D41FFE8-808E-4B81-A1AA-4D8D039C1CA4Q33318466-95277266-28B8-403E-BBA4-65AB698780A1Q34373653-8BDD62EB-0443-4A94-88CD-DE105A40B935Q34634916-480D2556-7E67-4AD0-B0FC-994B5111B784Q35063553-DFBF86A6-AE36-40E6-BF73-31D3D2A0B4F9Q35780393-01DD7913-4802-412E-AB76-323297075591Q35846177-F3040ACD-48E2-4C9E-B061-36801E0A38F0Q35924716-C6583325-B0FD-4721-B0B6-9757C7C6E92DQ36231432-ED901EB5-93B1-4658-9B9E-ED37A8A25231Q36312453-16BB86BE-9F0A-4443-9B10-7B524E933D67Q36313990-BA9D2415-4A32-4F78-9D96-9AF3683B2571Q36343693-5E38C27A-4E56-4AF8-B70D-CBE0ED767D61Q36345653-7796AD82-905D-468E-8114-CEA01770B457Q36346627-6C91E3FF-4413-466F-AE53-7045A8FDD8EEQ36349218-C15821E0-8634-48ED-86D5-26E799FEDD89Q36434929-A414D42E-8692-4D9C-8777-99B72A1C1271Q36641624-E80B9CFC-E930-4CBD-9AC3-75367816CBF8Q36668561-5632508F-EAC1-480A-999C-03265F79879BQ36674716-BD165F97-D98D-430D-805C-96C459DD719EQ36786513-5B338ADA-5C8C-4318-B5E3-3C035DD11258Q36800035-C6A47E00-B517-4086-95DE-E349BFF48C78Q36944687-32D0116A-065E-4B7E-BBB6-0500825050D6Q36954542-FD64C406-9EB4-44DA-8D4F-35F89B46007BQ36993585-D3F201B1-CAAB-4EB3-AB5B-D4DEC7E2C63BQ37020185-E0FE0653-C6B5-4340-B422-8DC09581E4DEQ37028297-89DEBDB3-8A7C-4F20-9B3F-CCC5ACBA89F8Q37034348-870A5A80-B1E5-4B1B-B63A-07E22F29A34FQ37075435-6DCC1644-84C0-4FFA-AD39-474524214E64Q37143190-CA929268-1948-4E4A-A364-FE3F5AE57B5AQ37254129-BC87A359-CF61-4C12-A2AE-3F9BA515D0C5Q37336064-3F3A16C8-BE2C-4285-BAC8-51626F0A6AC8Q37525951-C9F1FC1E-5847-4BF0-AAB5-ACD1ABBAB28FQ37800094-20104EDC-8077-4310-82C1-28DB085333C5Q38891923-237A49B9-B21C-475E-889B-BB97AD9543E3Q38892110-9E81229D-071B-4499-9050-ED4B8AD4BA80Q40153006-02051855-A80A-454F-B1D2-D19B682E3D09Q40205403-39BC4B1D-F608-4CAB-8D96-149B23FACFBA
P2860
Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Protective immunity produced b ...... f immune serum on sporozoites.
@en
Protective immunity produced b ...... f immune serum on sporozoites.
@nl
type
label
Protective immunity produced b ...... f immune serum on sporozoites.
@en
Protective immunity produced b ...... f immune serum on sporozoites.
@nl
prefLabel
Protective immunity produced b ...... f immune serum on sporozoites.
@en
Protective immunity produced b ...... f immune serum on sporozoites.
@nl
P2093
P1433
P1476
Protective immunity produced b ...... f immune serum on sporozoites.
@en
P2093
J Vanderberg
R Nussenzweig
P304
P577
1969-09-01T00:00:00Z